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Abstract
Background: Helicobacter pylori (H. pylori) is a micro-aerophilic, spiral-shaped, motile bacterium that is the principal
cause of gastric and duodenal ulcers in humans and is a major risk factor for the development of gastric cancer.
Despite provoking a strong innate and adaptive immune response in the host, H. pylori persists in the gastric
mucosa, avoiding eradication by macrophages and other phagocytic cells, which are recruited to the site of
infection. Here we have characterised the critical degradative process of phagosome maturation in primary human
macrophages for five genotypically and phenotypically distinct clinical strains of H. pylori.
Results: All of the H. pylori strains examined showed some disruption to the phagosome maturation process,
when compared to control E. coli. The early endosome marker EEA1 and late endosome marker Rab7 were
retained on H. pylori phagosomes, while the late endosome-lysosome markers CD63, LAMP-1 and LAMP-2 were
acquired in an apparently normal manner. Acquisition of EEA1 by H. pylori phagosomes appeared to occur by two
distinct, strain specific modes. H. pylori strains that were negative for the cancer associated virulence factor CagA
were detected in phagosomes that recruited large amounts of EEA1 relative to Rab5, compared to CagA positive
strains. There were also strain specific differences in the timing of Rab7 acquisition which correlated with
differences in the rate of intracellular trafficking of phagosomes and the timing of megasome formation.
Megasomes were observed for all of the H. pylori strains examined.
Conclusions: H. pylori appeared to disrupt the normal process of phagosome maturation in primary human
macrophages, appearing to block endosome fission. This resulted in the formation of a hybrid phagosome-
endosome-lysosome compartment, which we propose has reduced degradative capacity. Reduced killing by
phagocytes is consistent with the persistence of H. pylori in the host, and would contribute to the chronic
stimulation of the inflammatory immune response, which underlies H. pylori-associated disease.
Background
Helicobacter pylori (H. pylori) is one of the most success-
ful human pathogens, estimated to have infected half of
the world’s population [1]. H. pylori colonises the human
stomach, is the primary cause of gastric and duodenal
ulcers [2], and is a major risk factor for the development
of gastric cancer [3,4]. H. pylori strains have been tradi-
tionally classified into two types on the basis of virulence
factors [5]. Virulent type 1 strains secrete an active form
of the vacuolating cytotoxin VacA (s1/m1) and possess
the pathogenicity island cagPAI, whereas avirulent type 2
strains secrete an inactive form of VacA (s2/m2) and do
not possess the cagPAI [6-8].
The hallmark of H. pylori infection is chronic inflam-
mation of the gastric mucosa. H. pylori stimulates gastric
epithelial cells to release pro-inflammatory cytokines,
which recruit large numbers of neutrophils and macro-
phages to the site of infection [9-11]. Macrophages have
been demonstrated to effectively phagocytose H. pylori,
however in most cases this immune response fails to era-
dicate the bacterium from the host, suggesting that
H. pylori has developed mechanisms to avoid phagocytic
killing [12-15].
Although the predominant phagocytic cell type in the
H. pylori-infected gastric mucosa is neutrophilic, signifi-
cant numbers of macrophages are also found at the site
of infection. Macrophages are critical regulators of the
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both innate and adaptive immunity. Macrophages first
facilitate the innate immune response by phagocytosing
bacteria and then initiate the adaptive immune response
through antigen presentation and the secretion of cyto-
kines that direct lymphocyte recruitment and differen-
tiation. H. pylori has been shown to be efficiently
internalised by macrophages, but it avoids phagocytic
killing. In vitro studies have shown that live H. pylori
can be recovered from within human monocytic cell
lines and primary human macrophages, up to 48 hours
after infection [16-18]. Although the mechanism that
H. pylori employs to avoid phagocytic killing is not com-
pletely understood, some disruptions to the normal pro-
cess of phagosome maturation have been noted in
H. pylori-infected macrophages.
The normal process of phagosome maturation has
been characterised as the step wise interaction of phago-
somes with early endosomes, late endosomes and lyso-
somes [19,20]. Newly formed phagosomes interact with
early endosomes, gaining early endosome markers such
as Rab5 and EEA1. After 10-30 minutes, the early endo-
some markers are lost from the phagosome and are
replaced by late endosome markers, such as Rab7 and
CD63. After approximately one hour, the late endosome
markers are lost and phagosomes fuse with lysosomes to
become phago-lysosomes, with a full complement of
lysosomal hydrolytic enzymes and maximum degradative
capacity. Phago-lysosomes can best be characterised by
the presence of the lysosome associated membrane pro-
teins LAMP-1 and LAMP-2 [21].
It has been hypothesized that H. pylori arrests the nor-
mal phagosome maturation process at a stage prior to
the phagosome reaching full degradative capacity, thus
allowing for prolonged bacterial survival in a non-lethal
intracellular niche [22]. Previous reports on the composi-
tion of the H. pylori compartment in macrophages have
provided evidence for differences between phagosomes
containing virulent type 1 and avirulent type 2 strains of
H. pylori [16]. Avirulent type 2 strains of H. pylori have
been reported to undergo normal phagosome maturation,
resulting in a fully degradative phago-lysosome compart-
ment [16]. Conversely, virulent type 1 strains of H. pylori
have been reported to disrupt phagosome maturation,
and generate abnormal compartments termed megasomes
[16,17,23,24]. Megasomes are believed to arise due to the
homotypic fusion of H. pylori phagosomes, resulting in a
communal compartment with less degradative capacity.
Megasomes containing virulent type 1 strains of H. pylori
have been reported to retain the early phagosome marker
coronin 1 and the early endosome marker EEA1, but
exclude the lysosomal marker LAMP-1 [16,17,24]. The
specific H. pylori virulence factors responsible for pro-
longed intracellular survival and disturbed phagosome
maturation are beginning to be investigated. In vitro stu-
dies in mouse peritoneal macrophages and macrophage
cell lines, utilising isogenic mutant strains of H. pylori,
have demonstrated that VacA and urease were both
essential for the prolonged survival of H. pylori, but only
urease deletion mutants were unable to form megasomes
[17,24].
To our knowledge, there has not been a systematic time-
course study undertaken to characterise the H. pylori pha-
gosome and this has led to potential misconceptions on
H. pylori phagosome maturation. Utilising a set of markers
to define early endosomes, late endosomes and lysosomes,
we have characterised and compared the sequential steps
in the phagosome maturation process for five genotypi-
cally and phenotypically distinct clinical isolates of
H. pylori,a n dac o n t r o lE. coli strain, using a primary
human macrophage model of infection.
Methods
Bacterial strains and culture conditions
The H. pylori isolates used in this study were typed for
the vacuolating cytotoxin (VacA) and cag pathogenicity
island (cagPAI) virulence factors by polymerase chain
reaction, and for the expression of CagA protein by
Western analysis as previously described [18]. The SS1
(Sydney Strain 1) strain [25] had the vacA genotype
s2/m2, and was positive for the cagPAI and expressed
the CagA protein. NL101 was vacA s1a/m1, cagPAI
positive, CagA negative. NL103 was vacA s2/m2, cagPAI
negative, CagA negative. NL106 was vacA s2/m2, cag-
PAI positive, CagA negative. NL107 was vacA s1a/m1,
cagPAI positive, CagA positive. The E. coli DH5a strain
[26] was used as a control in this study.
Plate cultures of bacteria were grown on Columbia
agar plates (Oxoid, Basingstoke, UK) containing 5%
(v/v) horse blood (Institute of Medical and Veterinary
Science (IMVS), Adelaide, South Australia). E. coli
DH5a was incubated overnight at 37°C in aerobic con-
ditions. H. pylori strains were routinely incubated for 3
days at 37°C under microaerophilic conditions (5% O2,
10% CO2). For the intracellular survival experiments,
lysates from the H. pylori-infected macrophages were
incubated for up to 5 days to allow sufficient time for
visible colonies to be formed.
Preparation of primary human macrophages
Human peripheral blood mononuclear cells (PBMCs)
were isolated from whole blood by centrifugation on
Ficoll-Paque™ PLUS (GE Healthcare, Sweden) gradients
and cultured as previously described [18], but with the
following adaptations for immunofluorescence experi-
ments. PBMCs were plated onto 22 × 22 mm glass cov-
erslips in 6 well tissue culture plates and incubated for
2 hours (37°C, 5% CO2)t oa l l o wf o rt h em o n o c y t e st o
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aspiration and vigorous washing with phosphate buf-
fered saline (PBS). The monocytes were cultured in
Basal Eagle cell culture medium (MP Biomedicals,
Irvine, CA) containing 20% (v/v) foetal bovine serum
(JRH Biosciences, Lenexa, KS, USA), at 37°C in 5% CO2
for 7 days, to allow their differentiation into macro-
phages. Macrophage differentiation was routinely con-
firmed by immunofluorescence staining, using an
antibody to the macrophage specific marker CD206 sup-
plied by BD Biosciences Pharmingen, San Diego, CA,
USA (data not shown).
Bacterial infection of primary human macrophages
Primary human macrophages were infected with either
H. pylori or E. coli suspensions in cell culture medium
(see above) at a multiplicity of infection of 50 bacteria
per cell. Wet mounts of the H. pylori suspensions were
examined microscopically on the day of infection to
determine that the bacteria were of the viable spiral
form. The viability of H. pylori and E. coli in the inocula
was confirmed by viable counts of the 0.5 McFarland
suspensions of H. pylori and E. coli (CFU/mL between 1
and 2 × 10
8 CFU/mL, data not shown). Contact
between the bacteria and the macrophages was facili-
tated by centrifugation of the tissue culture plates at
1,000 g for 3 minutes at 20°C. Phagocytosis was initiated
by incubation at 37°C in 5% CO2 a n da l l o w e dt op r o -
c e e df o re i t h e r0 ,1 5o ram a x i m u mo f3 0m i n u t e s .
Extracellular bacteria were then removed by thorough
washing with PBS (5 times using 3 mL per wash). The
final washes were plated and incubated as above (for 5
days) to ensure no residual live bacteria remained out-
side of the macrophages after these treatments. This
optimised infection protocol resulted in macrophages
containing approximately 10-15 phagosomes per cell.
For the H. pylori killing experiments; infected macro-
phages were cultured for 2 hours, 8 hours or 24 hours
following the initiation of phagocytosis before being
lysed (0.1% saponin, 15 minutes at 37°C), and the viable
bacteria enumerated by scoring colonies of plated serial
dilutions of the macrophage lysates. An additional 30
minute time-point was included for the E. coli killing
experiments to confirm that the number of E. coli inter-
nalised by macrophages was comparable to that
observed for H. pylori. All infections were performed in
triplicate, with viable counts performed in duplicate. For
the immunofluorescence experiments, infected macro-
phages were cultured for 0 minutes, 15 minutes, 30
minutes, 2 hours or 4 hours following the initiation of
phagocytosis, before being fixed in 50% methanol/acet-
one (v/v) for 10 minutes on ice. Fixed coverslips were
stored overnight at 4°C in PBS before immunofluores-
cence staining.
Preparation of LAMP-1 antibody
Sheep anti-human LAMP-1 antibody was a kind gift
from Debbie Lang, Children Youth and Women’s Health
Service (CYWHS), North Adelaide, South Australia.
Recombinant human LAMP-1 was expressed and puri-
fied as previously described [27], then conjugated to
diphtheria toxoid for immunisation (Mimotopes, Mel-
bourne, Victoria). Polyclonal antibody production in
sheep was by a standard immunisation regimen (IMVS,
Veterinary Services Division, Gilles Plains, South Austra-
lia) and followed the Australian code of practice for the
care and use of animals for scientific purposes. Briefly, a
sheep was primed by multiple subcutaneous injections
of a total of 1 mg of protein in Freund’s Complete Adju-
vant. Three subsequent injections of 1 mg of protein in
Freund’s Incomplete Adjuvant were given at 3 week
intervals. Two weeks after the final injection the sheep
was exsanguinated and the serum collected. The poly-
clonal antibody was purified by affinity chromatography.
Immunofluorescence analysis
Coverslips were blocked with 5% (w/v) bovine serum
albumin (BSA; Sigma-Aldrich, St. Louis, MO, USA) in
PBS for 1 hour at room temperature. Primary and sec-
ondary antibody solutions for immune detection were
prepared in 5% BSA in PBS. H. pylori was detected with
a 1/100 dilution of caprylic acid purified rabbit anti-
H. pylori serum [18] and E. coli was detected with
130 μg/mL of rabbit anti-E. coli serum (Dako, Glostrup,
Denmark). The antibodies to endosome-lysosome mar-
kers were: mouse anti-human Rab5 (BD Biosciences
Pharmingen, San Diego, CA, USA; 5 μg/mL), goat anti-
human EEA1 (Santa Cruz Biotechnology, Santa Cruz,
C A ,U S A ;4μg/mL), mouse anti-Rab7 (Sigma-Aldrich;
2.2 μg/mL), mouse anti-human CD63 (kind gift from
Andrew Zannetino, IMVS, Adelaide, South Australia,
[28]; 5 μg/mL), sheep anti-human LAMP-1 (2.26 μg/
mL), and mouse anti-human LAMP-2 (kind gift from
Caroline Dean, CYWHS, North Adelaide, South Austra-
lia, [29]; 3.37 μg/mL). After incubation for 2 hours at
room temperature, unbound primary antibodies were
removed by washing 3 times with PBS. Primary antibo-
dies to the bacteria were detected with a 1/100 dilution
of FITC-conjugated donkey anti-rabbit antibody (Che-
micon International, Millipore, Temecula, CA, USA). Pri-
mary antibodies to the endosome-lysosome markers were
detected with a 1/500 dilution of Cy3-conjugated respec-
tive secondary antibody: either donkey anti-mouse (Rock-
land Immunochemicals, Gilbertsville, PA, USA), donkey
anti-goat or donkey anti-sheep (Chemicon). After incu-
bation for 1 hour at room temperature, unbound second-
ary antibodies were removed by washing as described
above. The coverslips were mounted with ProLong
Gold
® antifade containing DAPI (Invitrogen Corp.
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at room temperature in the dark before examination and
imaging by confocal microscopy.
Confocal microscopy and co-localisation analysis
For fluorescence imaging, confocal microscopy was per-
formed using a Leica SP5 Laser Scanning Spectral Confo-
cal Microscope (Adelaide Microscopy, University of
Adelaide, South Australia). Macrophages containing 10-
15 phagosomes were screened from each of two indepen-
dent experiments and representative images were taken
for co-localisation analysis. Images were collected and
analysed using the Leica Application Suite for Advanced
Fluorescence software (Leica Microsystems, Wetzlar,
Germany). For co-localisation analysis, a scatter-plot,
which correlated the colour and intensity of each pixel
with respect to the contribution from each of the red and
green channels, was generated for each image. Back-
ground threshold was set at 20% and the overlap coeffi-
cient was calculated as a statistical measurement of
co-localisation. The overlap coefficient averages used to
generate the graphs were determined from approximately
100 phagosomes for each treatment in duplicate experi-
ments. Fluorescence images were processed to create the
micrograph figures using Adobe Photoshop software
(Adobe Systems Inc., San Jose, CA, USA).
Ethics
The collection of human blood samples for the study of
H. pylori was approved by the University of South Aus-
tralia Human Research Ethics Committee (Ethics Proto-
col P129/08) and the Australian Red Cross Blood
Service (Agreement Number 08-06SA-05).
Results
Bacterial killing by primary human macrophages
The numbers of viable bacteria recovered from primary
human macrophages infected with either E. coli or
H. pylori w e r ed e t e r m i n e do v e ra2 4h o u rt i m ec o u r s e
(Figure 1). At thirty minutes and two hours after infection,
viable E. coli were recovered from infected primary human
macrophages, but no viable bacteria were recovered eight
Figure 1 Bacterial killing by primary human macrophages. The ability of primary human macrophages to kill E. coli strain DH5a (E. coli)w a s
compared to five H. pylori isolates (NL101, NL103, NL106, NL107 and SS1). The number of viable bacteria recovered from macrophages 30 minutes
(open bars) two hours (blue bars), eight hours (grey bars) or 24 hours (closed bars) after infection is represented in colony forming units per
millilitre (CFU/mL). Infected macrophage cultures were extensively washed to remove extra-cellular bacteria. Data is the mean of three
independent experiments.
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for all of the H. pylori strains examined, viable bacteria
were recovered from infected primary human macrophages
at two, eight and 24 hours after infection (Figure 1, NL101,
NL103, NL106, NL107 and SS1). This demonstrated that
E. coli DH5a was efficiently killed and therefore a suitable
control for phagosome maturation, in our primary human
macrophage model of infection.
Characterisation of phagosome maturation
The process of phagosome maturation in primary human
macrophages was defined by determining the amount of
Rab5, EEA1, Rab7, CD63, LAMP-1 or LAMP-2 that co-
localised with E. coli DH5a or H. pylori NL101, NL103,
NL106, NL107 and SS1 phagosomes at 0 minutes,
15 minutes, 30 minutes, two hours and four hours after
the initiation of phagocytosis (Figures 2, 3, 4).
Co-localisation of early endosome markers with E. coli
phagosomes
Rab5 showed a consistently low amount of co-localisation
with E. coli DH5a phagosomes, throughout the four hour
time-course (Figure 2, ECOL). In contrast, there was a
decrease in the amount of EEA1 that was co-localised
with E. coli DH5a phagosomes from a high immediately
after infection to a low at the 15 and 30 minute time-
points. At two and four hours after infection, the amount
of EEA1 co-localised with E. coli DH5a phagosomes was
equivalent to that seen for Rab5 (Figure 2, ECOL).
Co-localisation of early endosome markers with H. pylori
phagosomes
There were strain specific differences observed in the
acquisition of the early endosome markers by H. pylori
phagosomes. H. pylori NL101 phagosomes showed a
substantially higher amount of co-localisation with
EEA1 than with Rab5 immediately after infection. This
high level of EEA1 co-localisation was maintained
throughout the four hour time course. The amount of
Rab5 associated with H. pylori NL101 phagosomes
increased at 15 and 30 minutes after infection before
reaching a level similar to that seen for EEA1 at two
hours and four hours after infection (Figure 2, NL101).
H. pylori NL103 and NL106 phagosomes showed sub-
stantially higher co-localisation with EEA1 than with
Rab5 throughout the four hour time-course (Figure 2,
NL103 and NL106). In contrast, for H. pylori NL107
and SS1 phagosomes, there were similar levels of co-
localisation with EEA1 and Rab5 throughout the four
hour time-course. For H. pylori NL103 and NL106,
Rab5 showed low level co-localisation with phagosomes
throughout the four hour time-course (Figure 2, NL103)
even though NL103 showed increasing levels of co-loca-
lisation with Rab5 throughout the time course (Figure 2,
NL103). For H. pylori NL107, Rab5 and EEA1 co-locali-
sation with phagosomes increased over the first thirty
minutes following infection, decreased between 30 min-
utes and two hours, before stabilising at a low level at
two to four hours after infection (Figure 2, NL107). For
SS1, there were only low levels of co-localisation with
Rab5 and EEA1 throughout the time course and
although the amount of co-localisation increased at each
time point, the maximum co-localisation at four hours
was only low (Figure 2, SS1).
Co-localisation of late endosome markers with E. coli
phagosomes
Immediately after infection, E. coli DH5a phagosomes
showed some co-localisation with Rab7. The amount of
Rab7 associated with E. coli DH5a phagosomes remained
steady at 15 and 30 minutes after infection, before
increasing to a maximum at the two hour time-point and
decreasing at four hours after infection (Figure 3, ECOL).
There was little or no association of CD63 with E. coli
DH5a phagosomes at time zero after infection. The
amount of CD63 that was co-localised with E. coli DH5a
phagosomes increased at the 15 minute, 30 minute and
two hour time-points, to an amount that was maintained
at four hours after infection (Figure 3, ECOL).
Co-localisation of late endosome markers with H. pylori
phagosomes
There were also strain specific differences in late endo-
some marker acquisition by H. pylori phagosomes.
H. pylori NL107 phagosomes showed their maximum
amount of co-localisation with Rab7 immediately after
infection and this was maintained throughout the four
hour time course (Figure 3, NL107). In contrast, there
was little or no co-localisation of Rab7 with H. pylori
NL101, NL103, NL106 and SS1 phagosomes immediately
after infection. For NL101 and SS1 the amount of Rab7
associated with phagosomes increased at 15 minutes
after infection and reached a maximum at 2 hours after
infection and maintained this level of association at the
four hour time point (Figure 3, NL101 and SS1). For
NL103, it appeared that Rab7 did not become associated
with phagosomes until the two hour time point, but this
maximum amount of co-localisation was then main-
tained at the four hour time point (Figure 3, NL103). For
NL106, there was an increase in the amount of Rab7
associated with phagosomes at 30 minutes, however this
was at lower levels than for other strains and maximum
co-localisation was not achieved until four hours after
infection (Figure 3, NL106). All of the H. pylori strains
examined showed a similar pattern for the phagosomal
acquisition of CD63. There was little or no co-localisa-
tion of CD63 with phagosomes immediately after infec-
tion. The amount of CD63 co-localised with phagosomes
Borlace et al. Gut Pathogens 2011, 3:3
http://www.gutpathogens.com/content/3/1/3
Page 5 of 14Figure 2 Co-localisation of early endosome markers with H. pylori and E. coli phagosomes. Individual panels show the amount of co-
localisation between the early endosome markers Rab5 (open circle and dashed line) and EEA1 (closed circle and solid line) and H. pylori
(NL101, NL103, NL106, NL107, SS1) or E. coli (ECOL) phagosomes. Time-points were 0 minutes, 15 minutes, 30 minutes, two hours and four hours
following initiation of phagocytosis. Co-localisation between the bacteria (FITC) and early endosome markers (CY3) was quantified by calculating
the overlap coefficients from confocal immunofluorescence images of macrophages containing approximately 100 phagosomes for each
treatment, in duplicate.
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Page 6 of 14Figure 3 Co-localisation of late endosome markers with H. pylori and E. coli phagosomes. Individual panels show the amount of co-
localisation between the late endosome markers Rab7 (open triangle and dashed line) and CD63 (closed triangle and solid line) and H. pylori
(NL101, NL103, NL106, NL107, SS1) or E. coli (ECOL) phagosomes. Time-points were 0 minutes, 15 minutes, 30 minutes, two hours and four hours
following initiation of phagocytosis. Co-localisation between the bacteria (FITC) and late endosome markers (CY3) was quantified by calculating
the overlap coefficients from confocal immunofluorescence images of macrophages containing approximately 100 phagosomes for each
treatment, in duplicate.
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Page 7 of 14Figure 4 Co-localisation of LAMP-1 andLAMP-2 with H. pylori and E. coli phagosomes. Individual panels show the amount of co-
localisation between the lysosome markers LAMP-1 (open square and dashed line) and LAMP-2 (closed square and solid line) and H. pylori
(NL101, NL103, NL106, NL107, SS1) or E. coli (ECOL) phagosomes. Time-points were 0 minutes, 15 minutes, 30 minutes, two hours and four hours
following initiation of phagocytosis. Co-localisation between the bacteria (FITC) and LAMP-1 and LAMP-2 markers (CY3) was quantified by calculating
the overlap coefficients from confocal immunofluorescence images of macrophages containing approximately 100 phagosomes for each treatment, in
duplicate.
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NL106 and NL107), or two hours after infection (NL103
and SS1) and these maxima were maintained until the
four-hour time point (Figure 3).
Co-localisation of LAMP-1 and LAMP-2 with E. coli
phagosomes
Over the four hour time-course, LAMP-1 and LAMP-2
showed a similar pattern of co-localisation with E. coli
DH5a phagosomes as that observed for CD63. The
amount of LAMP-1 and LAMP-2 associated with E. coli
phagosomes increased at each time-point over the first
two hours, from a low immediately after infection to a
high that was maintained between two and four hours
after infection (Figure 4, ECOL).
Co-localisation of LAMP-1 and LAMP-2 with H. pylori
phagosomes
The pattern of lysosome marker acquisition by H. pylori
phagosomes was similar to that observed for CD63 for
all of the H. pylori strains examined. At time zero after
infection, LAMP-1 and LAMP-2 showed little or no co-
localisation with phagosomes. The amount of LAMP-1
and LAMP-2 co-localised with phagosomes steadily
increased at the 15 minute, 30 minute and two hour
time-points post-infection, and reached a maximum
between two and four hours after infection (Figure 4).
H. pylori internalised into macrophages were trafficked to
the peri-nuclear region at different times for each strain
Primary human macrophages were infected with H. pylori
and changes in the intracellular location of the bacteria
were tracked over a four hour time-course using confocal
immunofluorescence microscopy. During the course of
infection bacteria were observed to have been internalised
and trafficked from the cell surface/periphery, through the
cytoplasm to a destination at the peri-nuclear region
(Figure 5). The rate of trafficking from the cell surface to
the peri-nuclear region varied for the different H. pylori
strains (Table 1). H. pylori NL103 and NL106 appeared to
have the slowest transit times for the H. pylori strains
examined, not reaching the peri-nuclear region until the
two-hour time-point. H. pylori NL101 and SS1 phago-
somes were detected in the peri-nuclear region by 30 min-
utes after infection and the fastest transit time was
observed for H. pylori NL107, which had been re-located
to the peri-nuclear region by 15 minutes after infection.
H. pylori promotes formation of megasomes
A distinctive feature of H. pylori infected macrophages
was the appearance of megasomes, containing multiple
intact H. pylori (Figure 6). For each of the H. pylori
strains examined, the megasomes had a similar marker
composition to that observed for the phagosomes con-
taining a single bacterium. Thus, megasomes were char-
acterised by the retention of endosome markers EEA1,
Rab7 and CD63, despite recruiting the lysosome asso-
ciated membrane proteins LAMP-1 and LAMP-2 in an
apparently normal manner. However, in different bacter-
ial strains megasomes appeared at different time-points
(Table 2). They were detected at 15 minutes after infec-
tion for H. pylori strain NL107, at 30 minutes for
H. pylori strains NL101 and SS1 and not until two
hours for H. pylori strains NL103 and NL106.
Discussion
H. pylori infection is characterised by chronic inflamma-
tion of the gastric mucosa, which results in the
Figure 5 Intracellular location of H. pylori in infected macrophages. Confocal micrographs of primary human macrophages infected with H.
pylori NL103 immune stained with rabbit anti-H. pylori serum/donkey anti-rabbit FITC conjugate (green) and nuclear DNA stained with DAPI
(blue). The size and shape of macrophages are defined by dashed white lines. H. pylori are located at the cell surface/periphery at 0 and 15
minutes after infection (A), at an intermediate position between the cell periphery and the nucleus (cytoplasmic) 30 minutes after infection (B),
and in a peri-nuclear location two and four hours after infection (C). Scale bar = 5 μm.
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phagocytic cells. However, the persistence of H. pylori in
the host indicates that this immune response fails to
clear the infection. In vitro studies have demonstrated
that macrophages are unable to eradicate phagocytosed
H. pylori, and it has been postulated that this could be
due to impaired phagosome maturation [16-18,24,30].
Here we present a systematic time-course study of the
acquisition of early endosome, late endosome and
lysosome markers to accurately define the sequence of
the phagosome maturation process in five clinical strains
of H. pylori.
I nt h ef i r s ts t a g eo ft h ep h a g o s o m em a t u r a t i o np r o -
cess, phagosomes normally recruit markers characteris-
tic of early endosomes. Here we report that the early
endosome marker EEA1 was recruited to H. pylori pha-
gosomes in two distinct modes, either acquiring similar
amounts of Rab5 and EEA1 or larger amounts of EEA1
relative to Rab5. This suggested that some strains of
H. pylori could acquire EEA1 independently of Rab5.
The differences observed in the recruitment of Rab5
and EEA1 to H. pylori phagosomes correlated with the
CagA typing of the bacterial strains. The H. pylori
strains that were negative for CagA (NL101, NL103 and
NL106) appeared to recruit EEA1 independently of
Rab5, whereas the CagA positive H. pylori strain NL107
appeared to simultaneously recruit and lose Rab5 and
EEA1 over the time course. The H. pylori SS1 strain
produces a CagA protein that does not induce IL-8 pro-
duction from epithelial cells [31] and recruited only
small amounts of Rab5 and EEA1 over the time course.
For the CagA negative strains, there was a high level of
Table 1 Relative position of intracellular bacteria in
macrophages over a four hour time course
Bacterial Strain
NL101 NL103 NL106 NL107 SS1 E. coli
time after
infection
0 min CS/P CS/P CS/P CS/P CS/P CS/P
15 min Cy CS/P CS/P PN Cy Cy
30 min PN Cy Cy PN PN Cy
2h r PN PN PN PN PN PN
4h r PN PN PN PN PN PN
Intracellular position of H. pylori strains NL101, NL103, NL106, NL107, SS1 and
E. coli DH5a in primary human macrophages 0 minutes, 15 minutes, 30
minutes, 2 hours and 4 hours after infection. CS/P: cell surface/periphery, Cy:
cytoplasmic, PN: peri-nuclear.
Figure 6 H. pylori megasomes. Confocal immunofluorescence micrographs of megasomes in primary human macrophages 30 minutes after
infection with H. pylori strain NL101 (A) or NL107 (B). Infected macrophage are immune stained with rabbit anti-H. pylori serum/donkey anti-
rabbit IgG FITC conjugate (green), mouse anti-CD63/donkey anti-mouse IgG CY3 conjugate or sheep anti-LAMP-1/donkey anti-sheep IgG CY3
conjugate (red) and nuclear DNA stained with DAPI (blue). Arrows designate megasomes containing multiple intact H. pylori in overlay and
single channels. Scale bar = 5 μm.
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phagosomes also gaining the late endosome markers
Rab7 and CD63. In comparison, the CagA positive
strains either gained or lost their association with EEA1
(NL107) or gained only very low levels of EEA1 over the
four hour time course (SS1). This differential recruit-
ment of either early endosomes or early endosome traf-
ficking machinery to H. pylori phagosomes could
modulate the normal functioning of the endocytic com-
partments involved in for example, antigen presentation
and cytokine secretion, two functions of endosome-lyso-
some compartments that have been implicated in the
immune response to H. pylori infection. While the
mechanism connecting CagA and EEA1 acquisition is
unclear, there is an epidemiological association between
bacterial strains that produce CagA and the more severe
H. pylori disease outcomes, such as gastric cancer [32].
The next stage in the phagosome maturation process
involves the loss of early endosome markers from the
phagosome and concomitant gain of late endosome
markers [20]. Despite the strain specific differences that
were observed in the gain and loss of EEA1, all of the
H. pylori strains examined showed abnormal retention
of the late endosome marker Rab7 on their phagosomes,
when compared to E. coli. In addition, there were strain
specific differences observed in the timing of Rab7
recruitment to H. pylori phagosomes. Rab7 was acquired
by H. pylori NL107 phagosomes immediately after infec-
tion, by H. pylori N L 1 0 1a n dS S 1p h a g o s o m e s1 5m i n -
utes after infection, by H. pylori NL106 phagosomes 30
minutes after infection and by H. pylori NL103 phago-
somes two hours after infection. These differences in
the rate of Rab7 acquisition directly matched the transit
times of phagosomes to the peri-nuclear region. This
was consistent with the role of Rab7 to recruit down-
stream effectors that enable endosomes and lysosomes
to attach to the dynein/dynactin motor complex, for
trafficking along microtubules [33,34]. For all of the
H. pylori strains examined, both Rab7 and CD63 were
retained by phagosomes throughout the time course.
Table 2 The appearance of megasomes in H. pylori-infected primary human macrophages correlates with acquisition
of EEA1 and Rab7 and the intracellular position of the bacteria
H. pylori strain Time after infection EEA1 colocalisation Rab7 colocalisation Intracellular position Megasomes
NL101 0 min + - CS/P -
15 min + + Cy -
30 min + + PN +
2h r + + PN +
4h r + + PN +
NL103 0 min + - CS/P -
15 min + - CS/P -
30 min + - Cy -
2h r + + PN +
4h r + + PN +
NL106 0 min + - CS/P -
15 min + - CS/P -
30 min + - Cy -
2h r + - PN +
4h r + + PN +
NL107 0 min - + CS/P -
15 min + + PN +
30 min + + PN +
2h r + + PN +
4h r + + PN +
SS1 0 min - - CS/P -
15 min + + Cy -
30 min + + PN +
2h r + + PN +
4h r + + PN +
H. pylori clinical strains: NL101, NL103, NL106, NL107, SS1. Time after infection of primary human macrophages: 0 minutes, 15 minutes, 30 minutes, 2 hours and 4
hours. Intracellular position of H. pylori strains in infected primary human macrophages: CS/P; cell surface/periphery, Cy: cytoplasmic, PN: peri-nuclear. Association
of EEA1/Rab7 with H. pylori phagosomes and appearance of megasomes is either present (+) or absent (-).
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tion in the amount of phagosome associated Rab7 after
the two hour time-point. The retention of early and/or
late endosome markers by H. pylori phagosomes repre-
sented a significant departure from the normal phago-
some maturation process.
The final stage in the phagosome maturation process is
normally characterised by the loss of late endosome mar-
kers and fusion with lysosomes [20]. Previous studies have
suggested that H. pylori phagosomes acquire LAMP-1 dif-
ferently in various cell model systems. In the transformed
macrophage-like cell lines RAW264.7, J774 and THP-1, H.
pylori phagosomes have been reported to be LAMP-1
negative, whereas in primary mouse peritoneal macro-
phages, wild type H. pylori are reported to acquire limited
amounts of LAMP-1 [17,24]. Here, using primary human
macrophages, we observed that H. pylori phagosomes
acquired the lysosome associated membrane proteins
LAMP-1 and LAMP-2 with the same kinetics as observed
for E. coli phagosomes, despite retaining high levels of
early and late endosome markers. Taken together these
results indicated that while there appeared to be normal
recruitment of early endosomes and late endosomes-lyso-
somes by H. pylori phagosomes, there appeared to be
aberrant recovery of early and late endosomes during the
phagosome maturation process. This blockage in endo-
some fission resulted in the formation of hybrid phago-
some-endosome-lysosome compartments. While it is
possible to conclude that there could be two distinct sub-
populations of phagosomes positive for either early or late
endosome markers, the high amounts of co-localisation
suggest that this was unlikely. The retention of early and
late endosomes by H. pylori phagosomes, coupled with
normal phagosome-lysosome fusion, could result in larger
phagosome compartments. These hybrid compartments
would not be expected to have the same degradative prop-
erties as normal phagosomes, due to the increased size
and reduced concentration of lysosomal hydrolases. This
reduced phagosome degradative capacity could be respon-
sible for the failure of macrophages to eradicate H. pylori.
Megasomes containing multiple intact bacteria were
observed for all of the H. pylori strains examined in this
study, and showed the same marker composition as pha-
gosomes containing a single bacterium, in particular, the
retention of EEA1. The timing differences observed in
megasome formation for different H. pylori strains also
correlated with the timing of Rab7 acquisition by phago-
somes and the traffic of phagosomes to the peri-nuclear
region (Table 2). This confirmed and extended the model
for megasome formation proposed by Schwartz and
Allen [24]. EEA1/Rab7 positive H. pylori phagosomes
would be transported along the microtubule network to
the peri-nuclear region of the cell, in a Rab7 dependent
manner. The juxtaposition of EEA1 positive phagosomes
in the peri-nuclear region would then facilitate tethering
and phagosome fusion [35], in a manner analogous to
the homotypic fusion of early endosomes [36]. While the
r e t e n t i o no fE E A 1b ym e g a s o m e sh a sb e e nr e p o r t e dp r e -
viously, the acquisition of LAMP-1 by megasomes was
not described in a previous study [17]. Moreover, all
strains of H. pylori were observed to generate megasomes
in the current study, in contrast to previous reports of
only type 1 strains of H. pylori forming megasomes
[16,17]. These discrepancies may be explained by differ-
ent rates of early and late endosome marker acquisition
by each H. pylori strain, and consequently the timing of
megasome formation. The H. pylori in phagosomes and
megasomes appeared to have a rounded appearance and
H. pylori is known to take on a viable, but non-culturable
coccoid form in unfavourable environments [37]. How-
ever, despite the coccoid appearance, viable H. pylori
were cultured from the macrophages after 2, 8 and 24
hours following infection.
There are several different strategies employed by
intracellular pathogens to alter phagosome maturation
and avoid phagocytic killing. Mycobacterium tuberculo-
sis (M. tuberculosis) arrests phagosome maturation at
an early stage - it recruits Rab5, but blocks the recruit-
ment of Rab5 effectors [38,39]. Legionella pneumophila
establishes a replicative niche within an endoplasmic-
reticulum derived compartment [40] and Coxiella bur-
netii (the causative agent of Q fever) alters its intracel-
lular compartment to resemble an autophagosome
[41,42]. In contrast, H. pylori generates a unique,
hybrid phagosome-endosome-lysosome compartment
that retains some degradative capacity. This degrada-
tive capacity would account for the strong humoral
immune response that H. pylori evokes in the host
[43], as antigen presentation is critically reliant upon
degradation of phagosomal cargo. The limited degrada-
tive capacity of phagosomes would be consistent with
the long term persistence of H. pylori in the host and
the survival of residual numbers of H. pylori in
infected macrophages [16-18,23,24,30].
Conclusions
The normal phagosome maturation process was dis-
rupted in primary human macrophages that had been
infected by H. pylori. While there appeared to be normal
recruitment of early endosomes, late endosomes and
lysosomes by H. pylori phagosomes, there was aberrant
recovery of endosomes during the phagosome matura-
tion process. These disruptions of phagosome matura-
tion could contribute to the persistence of H. pylori in
the host and chronic stimulation of the inflammatory
immune response; a pre-cursor to all H. pylori asso-
ciated diseases. Identifying the molecular mechanism
that H. pylori uses to avoid macrophage-mediated killing
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Page 12 of 14could realise a strategy to reinstate the ability of the
immune system to clear this pathogenic bacterium.
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